Charlotte Höybye Selected Research

Prader-Willi Syndrome (Syndrome, Prader-Willi)

5/2021	An Adapted Model for Transition to Adult Care in Young Adults with Prader-Willi Syndrome.
1/2021	Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome.
11/2020	Hair cortisol-a method to detect chronic cortisol levels in patients with Prader-Willi syndrome.
10/2019	Letter regarding "Prevalence of growth hormone deficiency in previously GH-treated young adults with Prader-Willi syndrome" by Donze et al.
4/2015	Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition.
11/2013	Current status of growth hormone therapy in Prader-Willi syndrome.
6/2013	GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
4/2012	Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
8/2011	Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
11/2010	One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charlotte Höybye Research Topics

Disease

17	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2021 - 05/2003
5	Obesity 01/2006 - 10/2003
4	Insulin Resistance 01/2013 - 01/2004
3	Pituitary ACTH Hypersecretion 06/2022 - 01/2021
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 05/2003
2	Hyperprolactinemia 08/2021 - 09/2011
2	Hypertension (High Blood Pressure) 01/2021 - 12/2019
2	Neoplasms (Cancer) 01/2020 - 04/2004
2	Diabetes Mellitus 12/2019 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2019 - 09/2007
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2018 - 01/2016
2	Glucose Intolerance 01/2013 - 08/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2013 - 11/2012
2	Hyperphagia (Overeating) 02/2004 - 12/2003
1	Vision Disorders (Hemeralopia) 01/2022
1	Feeding and Eating Disorders (Eating Disorder) 01/2022
1	Cysts 01/2022
1	Uniparental Disomy 08/2021
1	Acid-Base Imbalance 07/2021
1	Infections 07/2021
1	COVID-19 07/2021
1	Hypernatremia 07/2021
1	Diabetes Insipidus 01/2021
1	Turner Syndrome (Turner's Syndrome) 01/2021
1	Pituitary Diseases (Disease, Anterior Pituitary) 12/2020
1	Addison Disease (Addison's Disease) 01/2020
1	Glucose Metabolism Disorders 12/2019
1	Hypothalamic Neoplasms 12/2019
1	Inflammation (Inflammations) 06/2019
1	Adenoma (Adenomas) 01/2019
1	Cognitive Dysfunction 01/2018
1	Fatigue 04/2017
1	Headache (Headaches) 04/2017
1	Hyperplasia 01/2017
1	Cushing Syndrome 01/2017
1	Pheochromocytoma 01/2017
1	Hyponatremia 07/2014
1	Scoliosis 11/2013
1	Craniopharyngioma (Craniopharyngiomas) 06/2013
1	Hypopituitarism (Sheehan's Syndrome) 04/2012
1	Prolactinoma (Prolactinomas) 09/2011
1	Heart Diseases (Heart Disease) 09/2007
1	Stroke (Strokes) 09/2007
1	Necrosis 01/2006
1	Rare Diseases (Rare Disease) 04/2004

Drug/Important Bio-Agent (IBA)

18	Growth Hormone (Somatotropin)IBA 01/2022 - 05/2003
5	Hormones (Hormone)IBA 01/2022 - 09/2007
5	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2021 - 01/2004
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2020 - 01/2013
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 04/2004
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 10/2003
3	Insulin (Novolin)FDA Link 01/2006 - 08/2002
3	LeptinIBA 01/2006 - 12/2003
2	ProlactinIBA 08/2021 - 09/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 06/2013
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2006
2	LipidsIBA 09/2011 - 01/2004
2	GhrelinIBA 02/2004 - 12/2003
2	Oxytocin (Pitocin)FDA LinkGeneric 02/2004 - 12/2003
2	Peptides (Polypeptides)IBA 02/2004 - 12/2003
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 08/2021
1	PotassiumIBA 07/2021
1	AcidsIBA 07/2021
1	ElectrolytesIBA 07/2021
1	SodiumIBA 07/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	Pharmaceutical Sleep AidsIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Vasopressins (Vasopressin)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2019
1	Urokinase Plasminogen Activator ReceptorsIBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	SteroidsIBA 01/2018
1	Ritonavir (Norvir)FDA Link 01/2018
1	Triamcinolone (Aristocort)FDA Link 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 04/2017
1	Analgesics (Analgesic Drugs)IBA 06/2013
1	Pioglitazone (Actos)FDA Link 01/2013
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2006
1	Protein CIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Triglycerides (Triacylglycerol)IBA 01/2006
1	CholesterolIBA 01/2006
1	AdiponectinIBA 01/2006

Therapy/Procedure

9	Therapeutics 12/2020 - 01/2004
2	Aftercare (After-Treatment) 06/2022 - 09/2011
1	Adrenalectomy 10/2021
1	Critical Care (Surgical Intensive Care) 07/2021
1	Length of Stay 07/2021
1	Transition to Adult Care 05/2021
1	Intra-Articular Injections 01/2018
1	Cesarean Section (Caesarean Section) 01/2016
1	Contraindications 11/2013
1	Operative Surgical Procedures 04/2004